Envista Holdings Corp (NVST)

USD 15.15

(0.83%)

Revenue Summary of Envista Holdings Corp

  • Envista Holdings Corp's latest annual revenue in 2023 was 2.56 Billion USD , down -0.1% from previous year.
  • Envista Holdings Corp's latest quarterly revenue in 2024 Q3 was 601 Million USD , down -5.07% from previous quarter.
  • Envista Holdings Corp reported a annual revenue of 2.56 Billion USD in annual revenue 2022, up 2.4% from previous year.
  • Envista Holdings Corp reported a annual revenue of 2.5 Billion USD in annual revenue 2021, up 9.94% from previous year.
  • Envista Holdings Corp reported a quarterly revenue of 633.1 Million USD for 2024 Q2, up 1.52% from previous quarter.
  • Envista Holdings Corp reported a quarterly revenue of 601 Million USD for 2024 Q3, down -5.07% from previous quarter.

Annual Revenue Chart of Envista Holdings Corp (2023 - 2016)

Historical Annual Revenue of Envista Holdings Corp (2023 - 2016)

Year Revenue Revenue Growth
2023 2.56 Billion USD -0.1%
2022 2.56 Billion USD 2.4%
2021 2.5 Billion USD 9.94%
2020 2.28 Billion USD -17.07%
2019 2.75 Billion USD -3.27%
2018 2.84 Billion USD 1.2%
2017 2.81 Billion USD 0.92%
2016 2.78 Billion USD 0.0%

Peer Revenue Comparison of Envista Holdings Corp

Name Revenue Revenue Difference
Alcon Inc. 10.09 Billion USD 74.569%
AptarGroup, Inc. 3.48 Billion USD 26.408%
Baxter International Inc. 14.81 Billion USD 82.674%
Becton, Dickinson and Company 20.17 Billion USD 87.281%
Bausch + Lomb Corporation 4.14 Billion USD 38.097%
Haemonetics Corporation 1.3 Billion USD -96.057%
ResMed Inc. 4.68 Billion USD 45.222%
Teleflex Incorporated 2.97 Billion USD 13.716%
Warby Parker Inc. 669.76 Million USD -283.194%
West Pharmaceutical Services, Inc. 2.94 Billion USD 12.994%